<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03962179</url>
  </required_header>
  <id_info>
    <org_study_id>19-1053_1</org_study_id>
    <nct_id>NCT03962179</nct_id>
  </id_info>
  <brief_title>Feasibility and Efficacy of a Combination of a SEMS and Vacuum Wound Treatment (VACStent)</brief_title>
  <acronym>VACStent</acronym>
  <official_title>VAC Stent: A Prospective Feasibility Study for the Treatment of Gastrointestinal Leakage Through a Combination of Covered Nitinol Stent and Negative Pressure Wound Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital of Cologne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital of Cologne</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Open, prospective, one-arm feasibility and efficacy study of a European conformity (CE)&#xD;
      certified Combination product of two CE certified medical devices in the intended indication.&#xD;
&#xD;
      Evaluation of the suitability of the medical device for sealing leaks in the gastrointestinal&#xD;
      tract&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators analyzed the outcome of using a hybrid medical device (self-expanding metal&#xD;
      stents (SEMS) with negative pressure wound therapy) in the treatment of leaks of the upper&#xD;
      gastrointestinal tract&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 22, 2019</start_date>
  <completion_date type="Anticipated">November 30, 2021</completion_date>
  <primary_completion_date type="Actual">November 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Technique - % of patients with successful implantation of VACStent</measure>
    <time_frame>From date of first implantation of VACStent until the leak is sealed or the treatment is canceled from any serious medical cause, whichever came first, up to 12 months</time_frame>
    <description>% of patients with successful implantation of VACStent</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Healing of leak - % of patients with successful implantation of VACStent</measure>
    <time_frame>From date of first implantation of VACStent until the leak is sealed or the treatment is canceled from any serious medical cause, whichever came first, up to 12 months</time_frame>
    <description>% of patients with a sealed leak after successful treatment with VACStent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment of sepsis</measure>
    <time_frame>From date of first implantation of VACStent until the leak is sealed or the treatment is canceled from any serious medical cause, whichever came first, up to 12 months</time_frame>
    <description>% of patients with successful treatment of sepsis leak after successful implantation of VACStent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Migration rate</measure>
    <time_frame>From date of first implantation of VACStent until the leak is sealed or the treatment is canceled from any serious medical cause, whichever came first, up to 12 months</time_frame>
    <description>% of patients with migration of VACStent after successful implantation of VACStent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding</measure>
    <time_frame>From date of first implantation of VACStent until the leak is sealed or the treatment is canceled from any serious medical cause, whichever came first, up to 12 months</time_frame>
    <description>% of patients with bleeding after successful implantation of VACStent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arrosion of tissue structures</measure>
    <time_frame>From date of first implantation of VACStent until the leak is sealed or the treatment is canceled from any serious medical cause, whichever came first, up to 12 months</time_frame>
    <description>% of patients with % of patients with bleeding after successful implantation of VACStent after successful treatment with VACStent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sealing of leak - % of patients with successful implantation of VACStent</measure>
    <time_frame>From date of first implantation of VACStent until the leak is sealed or the treatment is canceled from any serious medical cause, whichever came first, up to 12 months</time_frame>
    <description>% of patients with a sealed leak after successful treatment with VACStent</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Perforation Esophagus</condition>
  <condition>Esophageal Cancer</condition>
  <condition>Esophageal Achalasia</condition>
  <condition>Esophageal Diseases</condition>
  <arm_group>
    <arm_group_label>VACStent Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient s who received a VACStent</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VACStent</intervention_name>
    <description>Evaluation of the suitability of the medical device for sealing leaks in the gastrointestinal tract</description>
    <arm_group_label>VACStent Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with spontaneous, iatrogenic or postoperative leakage in the esophagus,&#xD;
             evidence of leakage through an endoscopic examination&#xD;
&#xD;
          -  Accessibility of the leak with the delivery system of the VAC stent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Simultaneous participation in other interventional exams&#xD;
&#xD;
          -  Endoscopic inaccessibility of the affected section&#xD;
&#xD;
          -  Full anticoagulation with international normalized ratio (INR) &gt; 1.5 and / or partial&#xD;
             thromboplastin time (PTT) &gt; 50 sec, or platelets &lt;20.000 / μl (after therapeutic&#xD;
             correction an inclusion is possible)&#xD;
&#xD;
          -  Unstable patients with severe septic disease, who have a clinical history&#xD;
&#xD;
          -  Assessment an immediate operation for safe focus switch-off requires&#xD;
&#xD;
          -  Ileus image with constant vomiting (after nasogastric tube and gastric emptying an&#xD;
             inclusion possible)&#xD;
&#xD;
          -  Persons who are in a dependency / employment relationship with the sponsor or examiner&#xD;
             stand&#xD;
&#xD;
          -  Accommodation in an institution for judicial or regulatory purposes arrangement&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Seung-Hun Chon, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Cologne</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital of Cologne</name>
      <address>
        <city>Cologne</city>
        <state>NRW</state>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>https://www.karger.com/Article/Abstract/512320</url>
    <description>A Novel Hybrid Stent with Endoscopic Vacuum Therapy for Treating Leaks of the Upper Gastrointestinal Tract</description>
  </link>
  <reference>
    <citation>Chon SH, Bartella I, Bürger M, Rieck I, Goeser T, Schröder W, Bruns CJ. VACStent: a new option for endoscopic vacuum therapy in patients with esophageal anastomotic leaks after upper gastrointestinal surgery. Endoscopy. 2020 May;52(5):E166-E167. doi: 10.1055/a-1047-0244. Epub 2019 Dec 2.</citation>
    <PMID>31791095</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>May 21, 2019</study_first_submitted>
  <study_first_submitted_qc>May 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 23, 2019</study_first_posted>
  <last_update_submitted>July 29, 2021</last_update_submitted>
  <last_update_submitted_qc>July 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital of Cologne</investigator_affiliation>
    <investigator_full_name>Seung-Hun Chon</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>Perforation Esophagus, Esophageal Anastomotic Leak,</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esophageal Achalasia</mesh_term>
    <mesh_term>Esophageal Diseases</mesh_term>
    <mesh_term>Esophageal Perforation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

